Form 483

New Jersey Laboratories Form 483, 2016-09-23

FDA issued a Form 483 to New Jersey Laboratories on 2016-09-23 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

New Jersey Laboratories · New Brunswick, United States · Issued September 23, 2016

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 Sep 2016
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Adetutu M Gidado

23 Sep 2016
21 CFR 211.160(b)(4)

Establishment of calibration procedures

Cited by Adetutu M Gidado

23 Sep 2016
21 CFR 211.165(e)

Test methods

Cited by Adetutu M Gidado

23 Sep 2016
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Adetutu M Gidado

Inspected site

NJNew Jersey LaboratoriesNew Brunswick, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere